Assessing the interplay between yeast cell wall supplementation and oral Salmonella vaccines in poultry immunity
Due to the increasing concerns over antibiotic-resistant bacterial strains, implementing alternative strategies has become crucial for poultry health. The use of Mannan-oligosaccharides (MOS) from Yeast cell wall (YCW), and the administration of oral vaccines, are strategies that can be leveraged to help reduce the incidence of Salmonella . When MOS enhances gut innate immunity, live attenuated Salmonella vaccines promote the development of a specific humoral response. However, studies have demonstrated the binding between MOS and Salmonella pathogenic strains, thereby raising questions about the effect of a YCW-supplemented diet on the live attenuated strains and the efficiency of these vaccines. Here, we show that despite this phenomenon, Salmonella vaccination is at least as effective among chickens fed with YCW as in the control group. No major differences were found in the circulating antibody titer, nor in the cytokines’ activation potential between the two groups. Furthermore, antigen-presenting cells’ class II major histocompatibility was overexpressed by 59.9%, and an increased frequency of 70.6% in mature B-cells among the treated animals was detected. Our results demonstrate that a YCW-supplemented diet has a time-specific but positive effect on the animal’s effective vaccine-induced protection. Therefore, even though binding between MOS and the vaccine may occur, it does not negatively impact the chicken’s immune protection.
Authors
- Virginie Marquis (ORCID: https://orcid.org/0000-0003-3609-3731)
- Lucie Verhaeghe
- Julie Schulthess
- Laurent Pineau (ORCID: https://orcid.org/0000-0001-7082-6746)
- Carole Maupin
- Elio Bobe
Institutions
- Institut Agro Rennes-Angers (FR)
- Lesaffre (France) (FR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1038/s41598-026-78190-1
- Primary Topic
- Animal Nutrition and Physiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Phileo by Lesaffre